Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 530 items.
Affected lot may result in a false negative for skin test (pecan nut allergy)
RecallHealth product recall | 2023-09-29
Affected lot may contain the presence of glass particulate.
RecallHealth product recall | 2023-09-20
Affected lot may be OOS for related compound CZ RC1
RecallHealth product recall | 2023-09-19
Affected lot may not be filled with the correct amount of leuprolide acetate.
RecallHealth product recall | 2023-09-12
Affected lot may result in a false negative for skin test (pecan nut allergy)
RecallHealth product recall | 2023-09-07
The stability assay is out of specification in the affected lots.
RecallHealth product recall | 2023-09-06
Affected lots may contain the undeclared ingredients sildenafil and tadalafil.
RecallHealth product recall | 2023-08-23
Affected lots may contain the undeclared ingredient sildenafil.
RecallHealth product recall | 2023-08-22
Linear barcode printed on the vial label is non-functioning.
RecallHealth product recall | 2023-08-21
Affected lots contain an undeclared ingredient (bimatoprost). Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-08-21
Product sold without market authorization (DIN) in Canada. Product contains undeclared ingredient, bimatoprost, that is listed on the prescription drug list
RecallHealth product recall | 2023-08-18
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT) or exceed the acceptable cumulative intake limit for (N-nitrosodimethylamine (NDMA) and NNORT).
RecallHealth product recall | 2023-08-16
Affected lot exceed the acceptable cumulative intake limit for N-nitrosodimethylamine (NDMA) and N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-16
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2023-08-14
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-14